Brian Stephany, M.D.
| Appointed: |
2004 |
| Gender: |
Male |
| Languages: |
English |
Nephrology and Hypertension
Transplantation Center
Biographical Sketch
Brian Stephany, MD, is an Associate Staff Member in the Department of Nephrology and Hypertension at the Glickman Urologic and Kidney Institute, as well as an Associate Staff Member in the Transplantation Center at Cleveland Clinic’s main campus. He is Co-Director of the Cleveland Clinic Nephrology Update Symposium. His research interests include chronic kidney disease management post-solid organ transplantation and novel therapies for glomerulonephritis.
He earned his medical degree from The Ohio State University College of Medicine and Public Health in Columbus, Ohio. He completed an internship and an internal medicine residency at University of Michigan Health System in Ann Arbor, Mich. He also completed a nephrology fellowship at Cleveland Clinic in Cleveland, Ohio.
Dr. Stephany is certified by the State Medical Board, a Diplomate of the American Board of Internal Medicine with additional certification in Nephrology.
He has published a number of manuscripts, book chapters and abstracts on topics such as chronic kidney disease, kidney transplantation, and tumor lysis syndrome, among many others.
He is a member of the American Society of Transplantation, the American Society of Nephrology and the National Kidney Foundation.
Education & Fellowships
| Medical School: | The Ohio State University College of Medicine and Public Health, Columbus, OH |
|
| Internship: | University of Michigan Health System, Internal Medicine, Ann Arbor, MI |
| Residency: | University of Michigan Health System, Internal Medicine, Ann Arbor, MI |
| Fellowship: | Cleveland Clinic, Nephrology/Hypertension, Cleveland, OH |
| Other Education: | (Undergraduate) John Carroll University, University Heights, OH |
Certifications
Nephrology
Internal Medicine
Professional Memberships
- American Society of Transplantation
- American Society of Nephrology
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 5/29/2009 the review process regarding Dr. Stephany’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
